Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +2,000 31,839
2023-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 32,068
2023-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −2,000 22,000
2023-05-04 Silva Paul M Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 Saltzman Edward C Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 Reinsdorf Judith A Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 Lacey David L. Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 Kunkel Lori Anne Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-04 GREGORY JULIA P Director Grant or award · Director Stock Option (right to buy) +25,000 25,000
2023-05-01 Wolff Stefani EVP and COO Sale −342 $9.88 $3K 6,113
2023-05-01 van Houte Hans Chief Financial Officer Sale −721 $9.88 $7K 78,930
2023-05-01 Ring Christine General Counsel Sale −682 $9.88 $7K 10,040
2023-05-01 Hansen Gwenn Chief Scientific Officer Sale −1,136 $9.88 $11K 26,632
2023-04-30 Wolff Stefani EVP and COO Option exercise +962 6,455
2023-04-30 Wolff Stefani EVP and COO Option exercise · Restricted Stock Units −962 10,582
2023-04-30 van Houte Hans Chief Financial Officer Option exercise +2,886 79,651
2023-04-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 31,747
2023-04-30 Ring Christine General Counsel Option exercise +1,924 10,722
2023-04-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 21,165
2023-04-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,206 27,768

Page 25 of 32 · 632 trades